Neuromodulation: Transcranial electric stimulation seen from within the brain

Computer models can make transcranial electric stimulation a better tool for research and therapy.
  1. Angel V Peterchev  Is a corresponding author
  1. Duke University, United States

The human brain seems well protected, encased within the skull. Yet something as simple as placing a pair of wet sponges onto someone's head and sending a weak electric current between them can actually alter the brain's activity. A refined version of this method – known as transcranial electric stimulation – has attracted considerable interest and is now being used to probe the workings of the brain and develop treatments for medical conditions such as depression, epilepsy or stroke.

Transcranial electric stimulation (or TES for short) has parallels with conventional drug treatments in the sense that delivering an electric field to the brain is analogous to delivering drug molecules into the body. So, just as it is important to know how the human body affects an administered drug (a field of research that is known as pharmacokinetics), in TES we need to know how much of the current applied to the scalp actually enters the brain, and where this current goes.

The 'pharmacokinetics of TES' remains contentious (Underwood, 2016), but is important for several reasons. First, it allows us to relate findings from experiments in which brain tissue from animals is stimulated directly to findings obtained via noninvasive applications in people. Second, it helps researchers optimize the process in order to target specific regions of the brain. Third, it enables researchers to compensate for the differences between individuals, and to standardize the exposure that they receive.

The only established approach for estimating the dose of TES delivered to an individual relies on a three-dimensional model of the subject's head that includes its different tissues and the attached electrodes, which is fed into a computer simulation (Figure 1). Such models have been available for some time (Datta et al., 2009), but they had been validated only partially and indirectly in humans or other primates (Edwards et al., 2013; Lee et al., 2015). Moreover, there are uncertainties about the electric properties of the tissues in these models.

Computational model of the electric field and current produced in an individual's head during transcranial electric stimulation.

(A) Electrodes (white and orange rectangles) are attached to the scalp and electric current is applied; the model of the head shown here is derived from a structural MRI scan. (B) Simulation showing the electric current per unit area (current density) in a section of the brain during transcranial stimulation: this image shows the scalp (outermost layer), skull, cerebrospinal fluid, gray matter and white matter. The highest current density values in the brain (blue) are 100-fold lower than those in the scalp (red). The high resistance of the skull means that the majority of the current is shunted in the scalp. The cerebrospinal fluid is highly conductive and this takes current away from the brain too. (C) Simulation showing the electric field on the surface of the brain. For this configuration, the electric field is strongest between the two electrodes. The model was created and visualized with the free SimNIBS software package (http://simnibs.de; Windhoff et al., 2013).

Now, in eLife, Lucas Parra and colleagues – including Yu Huang and Anli Liu as joint first authors – report how they have addressed these issues by combining elaborate computational modeling with recordings taken within the brains of ten people undergoing surgery for epilepsy (Huang et al., 2017). This sample size markedly exceeds that of other similar measurements (Opitz et al., 2016), and the three-dimensional models used are highly sophisticated too. Leveraging this setup, Huang et al. provide the most extensive and direct estimates of the TES electric field to date. They also confirm that computational models of TES can accurately recreate the electric field generated in a real brain.

Huang et al. – who are based at City College of the City University of New York, New York University School of Medicine and the Mayo Clinic – provide practical insights that should help others to implement the models as well. For accurate results, the individual scan should capture the entire head, from neck to crown. This is not the convention in clinical imaging, which currently only focuses on the brain, but Huang et al. get round this limitation by splicing the bottom portion of a standard model of a head onto the individual scans. To do this, the images must be properly cropped and morphed, though this feature has yet to be added to publicly available electric field modeling software.

Including a compartment for the cerebrospinal fluid (the colorless liquid that surrounds the brain) also makes the models more accurate. Appropriate imaging and image analysis methods are required to capture this layer as well as the skull, which are both quite thin (see Figure 1B). However, modelers can breathe a sigh of relief, because the data suggest that the different layers within the skull can be omitted from the models without significantly impacting their accuracy. The way that conductivity changes depending on the orientation of the current in the brain's white matter can similarly be ignored, at least for the mostly outer regions of the brain explored so far by Huang et al.

This work also underscores the present limitations of modeling. It is still uncertain exactly what values for tissue conductivity should be used, and whether it is acceptable to use the same values for everyone. Addressing this question requires further studies likely involving a range of techniques. For example, there are promising efforts to measure tissue conductivities directly during surgery (Koessler et al., 2017), or with other noninvasive techniques (Chauhan et al., 2017).

Even without making the absolute electric field estimates more accurate, existing modeling approaches and software appear suitable for measuring the relative strength of stimulation across brain regions, and predicting how an individual's anatomy might affect this. Indeed, the National Institutes of Health now requires that researchers applying for certain grants "use realistic head modeling" to characterize what electric field is delivered across the brain (NIH, 2017). All in all, it seems that the time is now right for wider adoption of 'pharmacokinetics' of transcranial brain stimulation.

References

Article and author information

Author details

  1. Angel V Peterchev

    1. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, United States
    2. Department of Biomedical Engineering, Duke University, Durham, United States
    3. Department of Electrical and Computer Engineering, Duke University, Durham, United States
    4. Department of Neurosurgery, Duke University, Durham, United States
    For correspondence
    angel.peterchev@duke.edu
    Competing interests
    AVP: An inventor on patents and patent applications and recipient of research and travel support as well as patent royalties from Rogue Research; research and travel support, consulting fees, as well as equipment loan from Tal Medical; patent application support from Magstim; and equipment loans from MagVenture, all related to technology for transcranial magnetic stimulation
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4385-065X

Publication history

  1. Version of Record published: March 28, 2017 (version 1)

Copyright

© 2017, Peterchev

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,742
    views
  • 255
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Angel V Peterchev
(2017)
Neuromodulation: Transcranial electric stimulation seen from within the brain
eLife 6:e25812.
https://doi.org/10.7554/eLife.25812

Further reading

    1. Neuroscience
    Mohsen Sadeghi, Reza Sharif Razavian ... Dagmar Sternad
    Research Article

    Natural behaviors have redundancy, which implies that humans and animals can achieve their goals with different strategies. Given only observations of behavior, is it possible to infer the control objective that the subject is employing? This challenge is particularly acute in animal behavior because we cannot ask or instruct the subject to use a particular strategy. This study presents a three-pronged approach to infer an animal’s control objective from behavior. First, both humans and monkeys performed a virtual balancing task for which different control strategies could be utilized. Under matched experimental conditions, corresponding behaviors were observed in humans and monkeys. Second, a generative model was developed that represented two main control objectives to achieve the task goal. Model simulations were used to identify aspects of behavior that could distinguish which control objective was being used. Third, these behavioral signatures allowed us to infer the control objective used by human subjects who had been instructed to use one control objective or the other. Based on this validation, we could then infer objectives from animal subjects. Being able to positively identify a subject’s control objective from observed behavior can provide a powerful tool to neurophysiologists as they seek the neural mechanisms of sensorimotor coordination.

    1. Medicine
    2. Neuroscience
    Yunlu Xue, Yimin Zhou, Constance L Cepko
    Research Advance

    Retinitis pigmentosa (RP) is an inherited retinal disease in which there is a loss of cone-mediated daylight vision. As there are >100 disease genes, our goal is to preserve cone vision in a disease gene-agnostic manner. Previously we showed that overexpressing TXNIP, an α-arrestin protein, prolonged cone vision in RP mouse models, using an AAV to express it only in cones. Here, we expressed different alleles of Txnip in the retinal pigmented epithelium (RPE), a support layer for cones. Our goal was to learn more of TXNIP’s structure-function relationships for cone survival, as well as determine the optimal cell type expression pattern for cone survival. The C-terminal half of TXNIP was found to be sufficient to remove GLUT1 from the cell surface, and improved RP cone survival, when expressed in the RPE, but not in cones. Knock-down of HSP90AB1, a TXNIP-interactor which regulates metabolism, improved the survival of cones alone and was additive for cone survival when combined with TXNIP. From these and other results, it is likely that TXNIP interacts with several proteins in the RPE to indirectly support cone survival, with some of these interactions different from those that lead to cone survival when expressed only in cones.